Li Yan
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetic Foot Ulcer Assessment and Management
- Diabetes Management and Research
- Thyroid Disorders and Treatments
- Nephrology top 1%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 22
- Diabetic Foot Ulcer Assessment and Management 13
- Diabetes Treatment and Management 12
- Thyroid Disorders and Treatments 12
- Nephrology 29
- Chronic Kidney Disease and Diabetes 18
- Co-authors
- Meng Ren (44 shared papers)Kan Sun (17 shared papers)Chuan He Yang (14 shared papers)Robert D. Christensen (6 shared papers)Diaozhu Lin (25 shared papers)Hua Cheng (16 shared papers)Chuan Wang (8 shared papers)Xiaowen Huang (1 shared paper)
- Journals
- Journal of Diabetes (17 papers)Frontiers in Endocrinology (10 papers)PLoS ONE (7 papers)Thyroid (7 papers)Diabetes Care (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Yan
345 papers receiving 11.3k citations
Li Yan's Hit Papers
Peers
Comparison fields: 5 of 173
- Endocrinology, Diabetes and Metabolism 2.9k
- Nephrology 615
- Rehabilitation 459
- Physiology 995
- Occupational Therapy 145
Countries citing papers authored by Li Yan
This map shows the geographic impact of Li Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yan more than expected).
Fields of papers citing papers by Li Yan
This network shows the impact of papers produced by Li Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yan. The network helps show where Li Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 357 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults Hit paper breakdown → | 2024 | 1250 |
| 2 | Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study Hit paper breakdown → | 2020 | 1181 |
| 3 | Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial Hit paper breakdown → | 2008 | 627 |
| 4 | Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China Hit paper breakdown → | 2020 | 251 |
| 5 | 2002 | 198 | |
| 6 | 2020 | 196 | |
| 7 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Hit paper breakdown → | 2023 | 185 |
| 8 | 2013 | 177 | |
| 9 | 2005 | 176 | |
| 10 | 2019 | 173 | |
| 11 | 2013 | 164 | |
| 12 | Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hit paper breakdown → | 2023 | 160 |
| 13 | 2019 | 134 | |
| 14 | 2015 | 133 | |
| 15 | 2012 | 128 | |
| 16 | 2019 | 111 | |
| 17 | 2017 | 108 | |
| 18 | 2021 | 102 | |
| 19 | 2022 | 91 | |
| 20 | 2020 | 87 |
About Li Yan
Li Yan is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cancer Research, Surgery and Rehabilitation, having authored 357 papers that have together received 11.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Chronic Kidney Disease and Diabetes (18 papers), Liver Disease Diagnosis and Treatment (14 papers), Metabolism, Diabetes, and Cancer (13 papers), Diabetic Foot Ulcer Assessment and Management (13 papers), Diabetes Treatment and Management (12 papers), Thyroid Disorders and Treatments (12 papers) and Wound Healing and Treatments (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Nephrology (615 citations), Rehabilitation (459 citations), Physiology (995 citations) and Occupational Therapy (145 citations). Li Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Meng Ren, Kan Sun, Chuan He Yang, Robert D. Christensen, Chuan He Yang, Diaozhu Lin, Hua Cheng, Chuan Wang, Xiaowen Huang and Feng Li. Their work appears in journals such as Journal of Diabetes, Frontiers in Endocrinology, PLoS ONE, Thyroid and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.